Zimbabwe has turned down a significant American health deal valued at 367 million US dollars (272 million pounds) spanning five years over Washington's request for confidential biological samples.
This rejection came to light following a official document dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".
An official representative has since stated that the United States was requesting health data for research and commercial gain but refused to guarantee the benefits from any future vaccines.
"We must now begin the difficult and regrettable process of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for continued talks to reach a deal suitable to both sides so the nation's critical HIV programme can continue.
Wider Context
This rejection comes after a similar case in Kenya, where a court suspended a similar health funding agreement after legal challenges were filed about the safety of citizens' medical information.
After returning to office recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
USAID had administered assistance for the US government, but Trump stated its spending was "inefficient" and his administration was seeking direct bilateral deals to boost transparency and responsibility.
Based on statements, Sixteen African countries have so far signed these new agreements, constituting over $18.3bn in committed funds.
Details of the Declined Agreement
The money for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".
"Our nation was requested to surrender its biological resources and data over an extended period, with no equivalent promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.
"Effectively, our country would provide the basic resources for medical research with no certainty that the end products would be accessible to our citizens if a future pandemic arise."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining structures already established through the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to manage potential global health emergencies.
"This mechanism is intended to ensure that when a nation provides its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the resources to develop them."
These objections regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We are open to ongoing discussions with our American counterparts on how future co-operation could be designed in a manner that respects the independence and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but suggested that negotiations should continue since much of the nation's HIV programmes were funded by external financing.
"Where technical issues arise, such as those involving data governance or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," it commented.
This impasse highlights the continuing debate between accepting vital international aid and protecting a country's data in an increasingly data-driven world.